First-of-its-kind Dual-Drug Therapy for Coronary De Novo Disease Moves Toward U.S. Clinical Phase Novel Nanoparticle Technology Platform Aims to Deliver…
Confidentially Provide Information Detailing Financial Wherewithal, Regulatory Experience and Oversubscribed Investor Interest Reduce Minimum Tender Requirement from 70% to 51%…